Each Butalbital, Aspirin, and Caffeine Capsule for oral administration contains: butalbital, USP, 50 mg; aspirin, USP, 325 mg; caffeine, USP, 40 mg.
Butalbital, Aspirin, and Caffeine Capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of Butalbital, Aspirin, and Caffeine Capsules in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.
Media Articles Related to Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine)
Study suggests worsening trends in headache management
Source: Anxiety / Stress News From Medical News Today [2015.01.12]
Each year more than 12 million Americans visit their doctors complaining of headaches, which result in lost productivity and costs of upward of $31 billion annually.
Salt, not high blood pressure, may be to blame for that headache
Source: Headache / Migraine News From Medical News Today [2014.12.15]
Departing from the belief that a special diet aimed at lowering high blood pressure can ease headaches, a new study suggests it is simply salt intake that is the culprit.
The Worst Headache of Your Life: Brain Hemorrhage Symptoms
Source: MedicineNet Brain Aneurysm Specialty [2014.12.01]
Title: The Worst Headache of Your Life: Brain Hemorrhage Symptoms
Category: Doctor's Views
Created: 4/23/2010 12:00:00 AM
Last Editorial Review: 12/1/2014 12:00:00 AM
Differences in nerve structure and function may help to explain how migraine headaches occur
Source: Headache / Migraine News From Medical News Today [2014.11.06]
Migraine linked to defective 'insulation' around nerve fibers, suggests study in Plastic and Reconstructive SurgeryA new study shows cellular-level changes in nerve structure and function that...
Preliminary results further confirms the effectiveness of electroCore's non-invasive vagus nerve stimulation treatment for headache
Source: Headache / Migraine News From Medical News Today [2014.10.27]
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore's hand held non-invasive vagus nerve stimulation (nVNS)...
Published Studies Related to Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine)
Butalbital in the treatment of headache: history, pharmacology, and efficacy. [2001.11]
Analgesics containing butalbital compounded with aspirin, acetaminophen, and/or caffeine are widely used for the treatment of migraine and tension-type headache. The butalbital-containing compounds are efficacious in placebo-controlled trials among patients with episodic tension-type headaches.Because of concerns about overuse, medication-overuse headache, and withdrawal, their use should be limited and carefully monitored.
A protocol for butalbital, aspirin and caffeine (BAC) detoxification in headache patients. [1990.07]
The abuse of the combination drug containing butalbital 50 mg, aspirin 325 mg and caffeine 40 mg (or BAC), is commonly recognized by headache specialists as causing headaches. Despite this widespread problem, there is not a published treatment regimen for the BAC detoxification of patients.The other two patients were still BAC free 18 and 14 months after detoxification.
Page last updated: 2015-01-12